Valuation a Key Investment Metric in a U.S. Value Stock Fund
June 15, 2015
Molecular Diagnostic Companies Aim to Capitalize on Decentralized Testing
September 18, 2014
Mitigating Risk Through Customized Asset Allocation
August 28, 2014
Sailer, Ryan M.
Cancer Immunotherapy a Top Focus in Biotechnology Sector
August 20, 2014
Xu, Y. Katherine
Top-Down Analysis Sets the Stage for Sector Emphasis
July 29, 2014
Burke, Frederic G.
Exercising Discipline with a Value Investing Philosophy
July 22, 2014
Elmaleh, Jacques R.
Consolidation in Medical Devices Sector Replacing R&D and Product Launches
June 20, 2014
Applying a Size and Style Responsive Strategy for Equity Returns
June 05, 2014
High Success Rates and Significant M&A in the Antibody Space
April 16, 2013
Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013
Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013
Medical Device Companies Outperform Benchmarks Despite European Concerns
February 19, 2013
Wuensch, Joanne K.